Using patent data to assess the value of pharmaceutical innovation.
Though many more patents emerge from industry sources, drug-related patents generated in the non-profit setting appear to have greater importance than patents arising from the commercial sector, which helps demonstrate the value non-profit research institutions can have in driving drug development.
Kesselheim
Aaron S
AS
Department of Health Policy and Management, Harvard School of Public Health, Harvard Medical School, USA.
Avorn
Jerry
J
D015706:Bibliometrics; D003362:Cost-Benefit Analysis; D004059:Diffusion of Innovation; D016527:Drug Costs; D055808:Drug Discovery / Q000191:economics* / Q000639:trends; D004345:Drug Industry; D006077:Government Agencies; D006801:Humans; D009939:Organizations, Nonprofit; D010330:Patents as Topic / Q000706:statistics & numerical data*; D014495:Universities